By Raghav Mahobe (Reuters) -Ironwood Pharmaceuticals Inc said on Monday it would buy Switzerland-based drug developer VectivBio Holding AG for $1.15 billion, adding a promising treatment for digestive disorders to …
Tag:
digestive
-
-
XIFAXAN® (rifaximin), TRULANCE® (plecanatide) and PLENVU® Research Posters Will Be Presented LAVAL, Quebec, May 18, 2022 — Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”) and its gastroenterology business, Salix …